- Home
- DERM vs SMWB Comparison
DERM vs SMWB Comparison
Compare DERM & SMWB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DERM | SMWB |
|---|---|---|
| Founded | 2014 | 2007 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Programming Data Processing |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 257.1M | 240.7M |
| IPO Year | 2021 | 2021 |
Fundamental Metrics
Financial Performance| Metric | DERM | SMWB |
|---|---|---|
| Price | $8.25 | $2.59 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 7 |
| Target Price | ★ $12.67 | $8.13 |
| AVG Volume (30 Days) | 82.7K | ★ 1.8M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $56,134,000.00 | N/A |
| Revenue This Year | $17.48 | $17.15 |
| Revenue Next Year | $55.83 | $14.61 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $4.97 | $2.22 |
| 52 Week High | $9.56 | $10.75 |
Technical Indicators
Market Signals| Indicator | DERM | SMWB |
|---|---|---|
| Relative Strength Index (RSI) | 51.55 | 21.38 |
| Support Level | $6.71 | $2.22 |
| Resistance Level | $8.71 | $7.92 |
| Average True Range (ATR) | 0.48 | 0.38 |
| MACD | 0.03 | -0.03 |
| Stochastic Oscillator | 57.68 | 14.10 |
Price Performance
Historical ComparisonAbout DERM Journey Medical Corporation
Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's current product portfolio includes eight FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.
About SMWB Similarweb Ltd.
Similarweb Ltd provides digital data and analytics that power critical business decisions. The group recognizes revenue from subscriptions to the platform and other subscription products on a straight-line basis over the term of the contract subscription period beginning on the date access to the platform is granted, provided all other revenue recognition criteria have been met. It has geographic presence in Israel, the United States, the United Kingdom, Asia Pacific, Europe, and Other. The group generates the majority of its revenue from the United States.